Search Within
Document Type
245-208-4
Applied Filters:
Keyword:'245-208-4'
Showing 1-30 of 41 results for "245-208-4" within Technical Documents
Data Sheet - M150
Pharmacol. 14(4), 621 (1976).
3. Shah, N.S., Donald, A.G. "Pharmacological effects and metabolic fate of levo-methadone during postnatal
development in rat." J. Pharmacol. Exp. Ther. 208(3), 491 (1991
Bright prospects - Solvents for spectroscopy Uvasol®EMD
99.0 0.0002 0.01 1.0 1.0 245 (15 %), 250 (50 %), 255 (60 %),
260 (85 %), 270 (98 %)
500 ml GL 1.02447.0500
2.5 l GL 1.02447.2500
Cyclohexane 99.9 0.0002 0.005 1.0 1.0 208
Product Information Sheet - E1383
quality control data
4. Supplier information
5. Holthuis, J.J.M. et al., Analytical Profiles of Drug Substances, 18, 121, (1989).
6. Martindale, The Extra Pharmacopoeia, 28th ed., 208 (1982).
7. Sieber
Quality Control Range Sheet- A6041-102and A6041-202
/mL IL-4 Control 1 265 - 551 pg/mL
Control 2 262 - 545 pg/mL Control 2 1414 - 2937 pg/mL
IL-10 Control 1
XP725 Antibody Number-Lot Number 071M4826
268
3.2 197 198 199 200 221 222 223 224 245 246 247 248 269 270 271 272
3.3 201 202 203 204 225 226 227 228 249 250 251 252 273 274 275 276
3.4 205 206 207 208 229 230 231
TB334 rLysozyme Solution
Van Dinther, J. (2002) inNovations 14, 2–5.
2. Burgess, R. R. (1991) Meth. Enzymol. 208, 3–10.
4
TB334 Rev. C 0503
United States & Canada 800-207-0144
Germany 0800 6931
Estapor®White Microspheres
Determination of IgE Complexes
and of total IgE by latex immunoassay. J Clin Chem
Clin Biochem 1987;25:245-51.
4. Rogé S, et al. Development of a latex agglutination
test with recombinant variant surface glycoprotein
Molecular Biology Reagents Insert: OmniPur®
-Free
9601
9602
9610
9612
9613
100 ml
500 ml
1 l
5 l
10 l
$28
$32
$45
$208
$335
Water, WFI Quality, Sterile Purified Water 4.86505.0500
4.86505.1000
4.86505.5000
4.86505.9010
PKH Dye Reference Guide
Recirculation, cellular lifetime 94, 150, 200, 207, 208
Proliferation, growth control 29, 126, 130
Differentiation, embryogenesis 4, 9, 29, 87, 126, 130, 148
Adhesion 69, 46, 196
Blood
Solvents Catalog
99.0 0.0002 0.01 1.0 1.0 245 (0.82), 250 (0.30), 255 (0.22),
260 (0.07), 270 (0.01)
500 ml GL 1.02447.0500
2.5 l GL 1.02447.2500
Cyclohexane 99.9 0.0002 0.005 1.0 1.0 208 (0.70), 220 (0.26), 230 (
Characterization of chloramphenicol acetyltransferase gene by multiplex polymerase chain reaction in multidrug-resistant strains isolated from aquatic environments
sequence
C-1 Sense cat I, 245–264 5V-GGTGATATGGGATAGTGTT-3V
C-2 Sense cat II, 15–35 5V-GATTGACCTGAATACCTGGAA-3V
C-3 Sense cat III, 307–326 5V-CCATACTCATCCGATATTGA-3V
C-4 Sense cat IV, 122–141 5V-CCGGTAAAGCGAAATTGTAT
Calbiochem Biologics 29.2
www.calbiochem.com
More Angiogenesis Related Products
Order your
FREE copy
now!
$ 88
$ 52
$ 208
$ 208
$ 129
To Order Call Customer Service at 800-854-3417
Biologics 29.2.qxd 3/31/2003
Apoptosis - Antibodies, Reagents and Kits
H WB IP IH Rb 100 µL AB3530 $205
Anti-BarH2 H M IH Rb 100 µg AB5720 $245
Anti-Barx1 H M WB IC IH Rb 100 µg AB5825 $245
Bax
Anti-Bax, NT H
ApopTag®Fluorescein Direct In Situ Apoptosis Detection Kit
the limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
ApopTag® Fluorescein Direct In Situ Apoptosis Detection Kit
the limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
ApopTag®Red In Situ Apoptosis Detection Kit
the limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
ApopTag® Red In Situ Apoptosis Detection Kit
the limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
Chrombook 2015 - The world of chromatography in your hands
(85 %), 245 (90 %),
270 (99 %)
Dichloro-
methane
stabilized
1.06044.1000 1 L GL 99.9 5 0.01 0.0002 0.0002 240 (70 %), 245 (90 %),
260 (99 %)1.06044.2500 2.5 L GL
1.06044.4000 4 L GL
1.06044.9010
ApopTag® Plus Peroxidase In Situ Apoptosis Detection Kit
the limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
ApopTag® Peroxidase In Situ Apoptosis Detection Kit
the limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
ApopTag®Peroxidase In Situ Apoptosis Detection Kit
the limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
Programming data for Spectrophotometer and Spectroquant Test Kits
0.446 115 288 161 0.333 115 288 161
0.573 145 363 203 0.428 145 363 203
0.711 175 438 245 0.531 175 438 245
0.833 200 500 280 0.622 200 500 280
0.956 225 563 315
ApopTag®Plus Peroxidase In Situ Apoptosis Detection Kit
the limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
ApopTag®Fluorescein In Situ Apoptosis Detection Kit
limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
ApopTag®Plus Fluorescein In Situ Apoptosis Detection Kit
limb deformity
in Hammertoe mutant mice by retinoic acid-induced cell death. Develop.
Dynamics 208:466-481.
2. Allen, D.J., S.A. Roberts, and B.V. Harmon. (1993) Spontaneous
spermatogonial apoptosis
XP725 Antibody List Lot 089K4791
peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d
206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d
208 Cytokeratin
XP725 Antibody List Lot 129K4831
peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d
206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d
208 Cytokeratin
XP725 Antibody List Lot 129K4830
peptide 4 C5176 3851 KRT4 M NP_002263.2 y n/d n/d
205 Cytokeratin peptide 7 C6417 3855 KRT7 M NP_005547.3 y n/d n/d
206 Cytokeratin 8.12 C7034 3860 KRT13 M NP_002265.2 ,NP_705694.2 y n/d n/d
208 Cytokeratin
Biologics 31.1
µg $ 200
Cat. No. 662076 25 µg $ 250
Cat. No. 662074 25 µg $ 250
Cat. No. 344273 5 mg $ 208
10 mg 338
Cat. No. 662073 50
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
IGF-II CULT 25 µg 01-142
IGF-I (resistant to IGFBPs) CULT 25 µg 01-189
IGF-I CULT 25 µg 01-208
IGF-I, biotin conj. WB HPLC 2 µg 01-212
Insulin-like Growth Factor-I, recombinant human Pur 100
Page 1 of 2